Home›Search›Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy

Springer Science and Business Media Deutschland GmbH · Germany

ISSN1432-0851

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

112

days submission → published

measured · last 20 articles · accept 79d

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

1.805

H-Indexi

162

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.987

Total Worksi

7,529

Total Citationsi

236,874

2yr Mean Citednessi

4.53

Open Impact Factor alternative

Aims & Scope

Subject areas: Immunology; Oncology; Cancer Research; Immunology and Allergy; Medicine (miscellaneous).

General Information

Country / RegionGermany

Primary LanguageEnglish

1st Year Published—

FrequencyTwelve No. A Year

StatusActive

Total Publications7,529

Publisher OrgSpringer Science+Business Media

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~14 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✗ No

📦 Long-term Preservation

PorticoCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

9/12 · 75%

✅

Do you know the journal / publisher?

Springer Science and Business Media Deutschland GmbH

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1432-0851

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, CLOCKSS

❌

Plagiarism detection in place?

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

165

7.4k

2019

342

12k

2020

320

8.7k

2021

233

4.8k

2022

223

3.4k

2023

301

2024

375

1.4k

2025

202

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ1

ImmunologyQ1

Immunology and AllergyQ1

Medicine (miscellaneous)Q1

OncologyQ1

Subject Classification

Web of Science Categories

ImmunologyOncology

Scopus Categories

ImmunologyCancer ResearchImmunology and AllergyOncologyMedicine (miscellaneous)

Research Topics (OpenAlex)

Immunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionCAR-T cell therapy researchT-cell and B-cell ImmunologyMonoclonal and Polyclonal Antibodies ResearchImmune cells in cancerGlycosylation and Glycoproteins ResearchImmune Response and InflammationVirus-based gene therapy research

Frequently asked questions about Cancer Immunology, Immunotherapy

Is Cancer Immunology, Immunotherapy a predatory journal?

PubScope has no integrity flags on record for Cancer Immunology, Immunotherapy: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Cancer Immunology, Immunotherapy?

Cancer Immunology, Immunotherapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 4.53.

Is Cancer Immunology, Immunotherapy indexed in Scopus and Web of Science?

Cancer Immunology, Immunotherapy is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Cancer Immunology, Immunotherapy?